Archive - February 2020
Keytruda hits endpoints in triple-negative breast cancer
Another mid-late stage Alzheimer’s flop, this time for Lilly
UK cancer patients able to ‘visualise’ treatment effects
China’s BrightGene successfully copies Gilead’s coronavirus hopeful remdesivir
FDA sets Q3 decision date for NS Pharma’s DMD drug
McCann Health launches creative careers programme in London and New York
Revenue growth at Ipsen numbs pain of palovarotene calamity
Merck chases Roche with triple-negative breast cancer data for Keytruda
